IMA (ImageneBio) Net earnings per share (EPS TTM)
ImageneBio Inc is accelerating the release of anti-tumor agents through partnerships with oncology centers. Simultaneously, Ikena Oncology is researching neoplasm metabolism to develop precision therapies. High testing costs and patent protection create barriers to entry for new players, while the current metric stands at 61.10. This EPS (TTM) price visualization, which assists in the basic asset valuation, is provided below.
IMA (Ikena Oncology, Inc.): analytical breakdowns and indicator data
- market value and analyst target forecast:
- business market valuation indicators:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Coefficient ImageneBio Inc|IMA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ImageneBio Inc|IMA - Company Aggregate Debts|Debts to Book Capitalization ImageneBio|IMA - Company Long-Term Debts|Short-Term Indebtedness Ikena Oncology|Immediate Liquidity ikenaoncology.com
- earnings and valuation multiples information:
IMA - Company Net Income|Net Profit Forecast ImageneBio Inc|IMA - P/E Multiple|Projected Price to Earnings Ratio ImageneBio Inc|IMA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|IMA - Operating profit EBITDA|Net earnings per share for the last four quarters Ikena Oncology|IMA - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months ikenaoncology.com|IMA - Net earnings per share growth this year|Expected earnings per share trend next year ImageneBio Inc
- sales and revenue indicators:
Fundamental company valuation:IMA - Ikena Oncology
For an objective valuation of ImageneBio Inc (IMA), analyzing the growth rates of net income per share over the last twelve months is critical. The annual EPS TTM trend, which recorded a value of 61.10, reflects revenue volatility during the clinical scaling phase of oncology drugs, where sharp fluctuations in the indicator signal molecule verification costs and determine the investment attractiveness of the issuer's capital.
Competitor analysis for ImageneBio Inc
argenx.com (ARGX) - Net earnings per share for the last 12 months|BNTX (BioNTech) - Net earnings per share for the last 12 months|Abivax Corp (ABVX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ADMA Bio|Earnings per share for the last 12 months PTGX (Protagonist Corp)|Net earnings per share (EPS TTM) IMVT|KNSA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) GRFS (Grifols)|Net earnings per share for the last four quarters Adaptive Biotech (ADPT)|CLDX - Earnings per share for the last twelve months|Aurinia Corp (AUPH) - Net earnings per share for the last 12 months|BCRX: Net earnings per share (EPS TTM)|veratx.com (VERA) - Net earnings per share (EPS TTM)|DNTH (Dianthus Therapeutics, Inc.) - Net earnings per share (EPS TTM)|PHVS - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) ABCL|TRML - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Precigen, Inc. PGEN|PHAR: Earnings per share for the last 12 months|Nektar Therapeutics Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Upstream Bio, Inc.|ZBIO: Net earnings per share (EPS TTM)|IMNM (Immunome Bio) - Earnings per share for the last twelve months|GOSS (Gossamer Bio, Inc.) - Net earnings per share (EPS TTM)|kalvista.com (KALV) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Septerna (SEPN)|PVLA - Net earnings per one share for the last twelve months|Savara Corp - Net earnings per share for the last 12 months|Earnings per share for the trailing year RIGL|AnaptysBio, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters astriatx.com ATXS|enGene (ENGN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RAPT|JBIO (Aerovate Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aclaris Therapeutics, Inc (ACRS)|Net earnings per share (EPS TTM) KYTX|Net earnings per share for the last four quarters tizianalifesciences.com|Earnings per share for the last twelve months Cabaletta Bio CABA|VTYX - Net earnings per share for the last 12 months|Theratechnologies Inc - Net earnings per share (EPS TTM)|AVTX - Net earnings per share (EPS TTM)|Eledon Pharmaceuticals (ELDN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AGEN (agenusbio.com)|CLYM (Climb Bio) - Net earnings per share (EPS TTM)|ZURA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATYR|Net earnings per share (EPS TTM) adagene.com (ADAG)|Earnings per share for the last twelve months Shattuck Labs STTK|Earnings per share for the trailing year EQ|CNTB - Earnings per share for the last twelve months|Immunic, Inc. (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx (IFRX) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months XFOR|ACET: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CELU|Net earnings per share for the last four quarters INmune Bio Inc|Earnings per share for the last twelve months Barinthus Bio BRNS|KZR - Net earnings per share for the last 12 months|SABS - Earnings per share for the last twelve months|akaritx.com (AKTX) - Net earnings per share for the last 12 months|ENLV (enlivex.com) - Net earnings per share for the last 12 months|Q32 Bio (QTTB) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months GeoVax Labs Inc|Earnings per share for the last 12 months EDSA (Edesa Biotech Corp)|Net earnings per share (EPS TTM) IBIO|CARM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Net earnings per share for the last four quarters Bolt Biotherapeutics Inc. (BOLT)|HCWB - Earnings per share for the last twelve months|Aptevo Therapeutics (APVO) - Net earnings per share for the last 12 months|AIM: Net earnings per share (EPS TTM)|Aditxt, Inc. (ADTX) - Net earnings per share (EPS TTM)|GRI (GRI Bio) - Net earnings per share (EPS TTM)|XRTX - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) HIND|REVB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Indaptus Therapeutics INDP|SCNI: Earnings per share for the last 12 months|CalciMedica Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Affimed|ALLK: Net earnings per share (EPS TTM)|HOOK (HOOKIPA Pharma) - Earnings per share for the last twelve months|IGMS (IGM Biosciences Inc.) - Net earnings per share (EPS TTM)|iteostherapeutics.com (ITOS) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocean Biomedical (OCEA)|TCBP - Net earnings per one share for the last twelve months|Third Harmonic Bio, Inc - Net earnings per share for the last 12 months
